Repeated subgingival instrumentation

重复龈下仪器
  • 文章类型: Journal Article
    目的:研究在治疗步骤I-II后,在开放口袋[残余探查袋深度(PPD)≥6mm和PPD4-5mm,探查出血(BoP)]中,一个或两个重复的龈下器械(RSI)在达到治疗终点(EoT)中的作用。
    方法:患有III-IV期牙周炎的25例患者(总共3,552个部位;1,450个开放口袋)接受了牙周治疗的I-II步骤,并在4-6周后重新评估周(T1)。残余袋在T1和3个月(T2)时接受RSI。计算T1,T2和6个月(T3)时的EoT(PPD<4或PPD<6BoP-)率。计算所需手术次数和治疗费用。
    结果:在T1时,67.6%的开放口袋达到了EoT。T1时残余PPD≥6mm(n=172),在T2和T3时,一次和两次RSI分别导致33.1%和45.9%的EoT。在残余PPD为4-5mm时,在T1时使用BoP(n=298),在T2和T3时,一次和两次RSI分别导致66.8%和72.1%的EoT。在两种情况下,T1时的PPD预测了RSI后的EoT,而牙齿类型仅在残余PPD4-5mmBoP+。在T1时,每位患者的平均手术次数和相关费用显着高于一次/两次RSI后。
    结论:在相当多的情况下,RSI可能在残留PPD4-5mmBoP和PPD≥6mm中达到EoT。
    结论:这些发现可能支持在手术入路之前给予一个/两个周期的RSI。
    背景:ClinicalTrials.gov标识号:NCT04826926。
    OBJECTIVE: To study the effects of one or two repeated subgingival instrumentations (RSI) in achieving the endpoints of therapy (EoT) in open pockets [residual probing pocket depth (PPD) ≥ 6 mm and PPD 4-5 mm with bleeding on probing (BoP)] after steps I-II of therapy.
    METHODS: Twenty-five patients (3,552 total sites; 1,450 open pockets) with stage III-IV periodontitis received steps I-II of periodontal therapy and were re-evaluated after 4-6 weeks (T1). Residual pockets received RSI at T1 and at 3 months (T2). EoT (PPD < 4 or PPD < 6 BoP-) rate at T1, T2 and 6 months (T3) was computed. The number of needed surgeries and treatment costs were calculated.
    RESULTS: At T1, 67.6% of open pockets achieved EoT. At residual PPD ≥ 6 mm at T1 (n = 172), one and two RSI resulted in 33.1% and 45.9% of EoT at T2 and T3, respectively. At residual PPD 4-5 mm with BoP at T1 (n = 298), one and two RSI resulted in 66.8% and 72.1% of EoT at T2 and T3, respectively. PPD at T1 predicted EoT after RSI in both cases, while tooth type only in residual PPD 4-5 mm BoP + . At T1, mean number of surgeries per patient and associated costs were significantly higher than after one/two RSI.
    CONCLUSIONS: RSI may achieve EoT in residual PPD 4-5 mm BoP + and PPD ≥ 6 mm in a considerable number of cases.
    CONCLUSIONS: These findings may support the administration of one/two cycles of RSI prior to surgical approach.
    BACKGROUND: ClinicalTrials.gov identification number: NCT04826926.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号